by rss feed | Sep 20, 2026 | Longeveron, News Feeds, weekly reads, XPRIZE Healthspan
Longeveron is a biotech focused on mesenchymal stromal/stem cells or MSCs. Its big news this year was a report in Cell Stem Cell about a potential benefit for frailty from its product laromestrocel. I’ll talk more about that and my concerns further down. Now...
